Mevalonate pathway—a source of substrates for sterol synthesis, protein isoprenylation and dolichol-linked n-glycosylation—is up-regulated in various cancers (including breast cancer) and p53 continuously suppresses its activity at the level of SREBF2 transcription factor (Moon 2019; Yu 2021). This evidence concerns the gene TP53 and breast carcinoma.